Navigation Links
DiaSorin Webinar Spotlights Primary Hyperaldosteronism From A to Z
Date:4/7/2016

The occurrence of primary hyperaldosteronism among general and resistant hypertensive populations is widespread, ranging from five to 20 percent. This disorder, which is considered a secondary form of hypertension—caused by improper secretion of aldosterone and activation of the mineralocorticoid receptor—is a highly treatable and potentially curable form of hypertension.

DiaSorin is sponsoring a new, free educational webinar, “Primary Hyperaldosteronism: From A to Z,” which will discuss the prevalence, pathophysiology, screening and diagnostic studies, and treatment options for patients with primary hyperaldosteronism so that physicians can accurately screen and identify cases. Continuing education credits will be offered through the PACE system.

The speaker is Jonathan Williams, MD, MMSc, assistant professor of medicine at Harvard Medical School, and associate physician at Brigham and Women’s Hospital, Division of Endocrinology, Diabetes, and Hypertension. Dr. Williams has devoted his research efforts to deciphering the intricate relationship between genetics and environment with respect to individual susceptibility to cardiometabolic disease. He has more than 40 original publications describing the physiologic and pathologic interplay of renin-angiotensin-aldosterone system activity and dietary salt intake in hypertension, insulin resistance, heart disease, and obesity. Dr. Williams is an active program developer, course director, and mentor for the Harvard Medical School’s Scholars in Clinical Research Program. His complete bio is found on the LabRoots website.

The free webinar, hosted by LabRoots, will be presented on April 14, 2016, at 9 am PT/11 am CT/12 pm ET.

For full details about the event, obtaining continuing education credits, and free registration, click here.

About DiaSorin:
DiaSorin Inc. offers the broadest, fully automated Infectious Disease and Specialty Diagnostics menu including the Best-in-Class Vitamin D. These quality assays are analyzed on the versatile LIAISON® XL platform. We provide value through sales, service and support solutions to clinical laboratories by consolidating their menu in order to streamline processes and increase efficiency.

About LabRoots:
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13322975.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. DiaSorin Announces New Webinar in Their Annual Vitamin D Series
2. Diasorin Announces New Webinar Highlighting Syphilis Diagnosis
3. LabRoots, Inc to Host DiaSorin Webinar that Tackles Clinical Conundrum of Vitamin D Testing and Treatment
4. LabRoots Hosts DiaSorin Webinar that Spotlights Herpes Serology Testing from the Public Health Perspective
5. Webinar: Comparing Prices in Group Health vs. Workers' Compensation
6. 1 EDI Source Presents the Big Picture in Final Healthcare HIPAA EDI Webinar of 2013
7. Register to Download the Webinar Playback -- Middle Market Insights: Banking, Lending and the Impact on M&A
8. Self-Pleasure as a Healing Practice, a Complimentary Sexual Health Webinar from Sinclair Institute®
9. Biopharm Insight Hosts Educational Webinar Ahead of American Society of Hematology Conference Next Month
10. Register to Join the Merrill DataSite's Webinar: Avoiding the Post-Merger Blues: How to Reduce the Risk of Post-deal Disputes
11. Life Technologies Announces New Webinar Learning Series with BioConference Live
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
Breaking Medicine Technology: